Nu-Med Plus (NUMD) Accumulated Expenses (2012 - 2025)
Nu-Med Plus (NUMD) reported Accumulated Expenses of $18009.0 for Q4 2025, up 22.35% on a YoY basis from $14719.0 in Q4 2024, and up 17.06% sequentially from $15384.0 in Q3 2025.
Nu-Med Plus (NUMD) Accumulated Expenses (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Accumulated Expenses data on file, last reported at $18009.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses rose 22.35% year-over-year to $18009.0; the trailing twelve-month figure through Dec 2025 stood at $18009.0 (up 22.35% YoY), and the FY2025 full-year result was $18009.0, up 22.35% from the prior year.
- Accumulated Expenses climbed to $18009.0 in Q4 2025, from $15384.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $144555.0 in Q3 2022 to a low of $1000.0 in Q4 2022.
- A 5-year average of $40143.2 and a median of $17531.0 in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses surged 750.93% in 2021 and slumped 98.92% in 2022, its largest moves.
- Tracing NUMD's Accumulated Expenses over 5 years: stood at $92555.0 in 2021, then tumbled by 98.92% to $1000.0 in 2022, then soared by 500.0% to $6000.0 in 2023, then jumped by 145.32% to $14719.0 in 2024, then gained by 22.35% to $18009.0 in 2025.
- Business Quant data shows NUMD's Accumulated Expenses at $18009.0 in Q4 2025, $15384.0 in Q3 2025, and $13493.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,009.00 |
| Sep 30, 2025 | 15,384.00 |
| Jun 30, 2025 | 13,493.00 |
| Mar 31, 2025 | 19,747.00 |
| Dec 31, 2024 | 14,719.00 |
| Sep 30, 2024 | 17,053.00 |
| Jun 30, 2024 | 19,094.00 |
| Mar 31, 2024 | 14,547.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 4,740.00 |
| Jun 30, 2023 | 3,479.00 |
| Mar 31, 2023 | 2,233.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 144,555.00 |
| Jun 30, 2022 | 134,555.00 |
| Mar 31, 2022 | 113,555.00 |
| Dec 31, 2021 | 92,555.00 |
| Sep 30, 2021 | 71,062.00 |
| Jun 30, 2021 | 56,042.00 |
| Mar 31, 2021 | 41,041.00 |